| Returns | 1W : -2.5% , 1M : -2.3%,1Y : 142.7% |
| LT : |
Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : High |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| HEALTHCARE GLOBAL ENTERPRISES | -2.5% | -2.3% | 142.7% |
| SYNGENE INTERNATIONAL | 6% | 12.9% | 108.2% |
| QUESS CORP | -8.7% | -20.5% | 163.2% |
| SECURITY AND INTELLIGENCE SERVICES INDIA | -2.7% | -12.4% | -7.4% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 2.1% | 5.6% | 16.3% |
| TEAMLEASE SERVICES | -5.7% | -5.7% | 88.1% |
| DELTA CORP | -5.6% | -22.6% | 95.7% |
| JUST DIAL | -0.5% | 0.3% | 141.6% |
| FERMENTA BIOTECH | 18.6% | 11.1% | 20.8% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
-
P/E Calculated based on EPS of -12.03
[ Mar2020 - Consolidated Results ] 4.3
P/B Calculated based on Book Value of 42.19
[ Mar2020 - Consolidated Results ] 2.23
P/S Calculated based on Revenues of 1020.22 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-10% -13% -15% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.7% | 15.3% | 56.9% |
| S&P BSE SMALL CAP | 0.5% | 2.5% | 90.8% |
| S&P BSE MIDSMALLCAP | 0.2% | 1.7% | 80% |
| S&P BSE ALLCAP | -0.8% | -0.3% | 59.7% |
